A polymorphism in the IL11 gene is associated with ulcerative colitis
- 1 December 2002
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 3 (8) , 494-496
- https://doi.org/10.1038/sj.gene.6363897
Abstract
Inflammatory bowel diseases (IBD) are multifactorial disorders characterised by the host's inability to limit the inflammatory response to luminal antigens. The association of polymorphisms in the CARD15 gene with Crohn's disease (CD) demonstrates the relevance of activated transcription factor NF(kappa)B in mononuclear cells. Interleukin 11 (IL11) mediates anti-inflammatory effects and is able to downregulate LPS-induced NF(kappa)B activation. The IL11 gene is therefore a good candidate involved in genetic predisposition to IBD. To evaluate the role of the IL11 gene in IBD, two polymorphisms, including a dinucleotide repeat in the promoter region, have been genotyped in 222 patients with CD, 152 patients with ulcerative colitis (UC) and 400 healthy controls. PCR-SSCP analysis of the coding region revealed a single polymorphism in exon 4 leading to an amino acid exchange (G335A; R112H), not significantly associated with either disease. Dinucleotide repeat frequencies of the IL11.A1 allele and of IL11.A1 homozygous individuals were significantly increased among the patients with UC (P < 0.002 and (P < 0.003, respectively) but not with CD. Altered expression of IL11 appears to be involved in the genetic predisposition of UC.Keywords
This publication has 21 references indexed in Scilit:
- The genetics of inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2001
- Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κBJournal of Biological Chemistry, 2001
- Interleukin-11 Modulates Th1/Th2 Cytokine Production from Activated CD4+T CellsJournal of Interferon & Cytokine Research, 2001
- Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesionsJournal of Clinical Investigation, 1999
- Interleukin‐11: Its Biology and Prospects for Clinical UseJournal of Parenteral and Enteral Nutrition, 1999
- Activation of nuclear factor kappa B in inflammatory bowel diseaseGut, 1998
- Genetic predisposition to multiple sclerosis as revealed by immunoprintingAnnals of Neurology, 1997
- Genomic simple repetitive DNAs are targets for differential binding of nuclear proteinsFEBS Letters, 1996
- Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)Clinical and Experimental Immunology, 1995
- Classification of Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1989